Stocks and Investing
Stocks and Investing
Mon, December 19, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Constantine Davides Initiated (VNRX) at Strong Buy and Held Target at $6 on, Dec 19th, 2022
Constantine Davides of EF Hutton, Initiated "VolitionRx Limited" (VNRX) at Strong Buy and Held Target at $6 on, Dec 19th, 2022.
Constantine has made no other calls on VNRX in the last 4 months.
There is 1 other peer that has a rating on VNRX. Out of the 1 peers that are also analyzing VNRX, 0 agree with Constantine's Rating of Hold.
This is the rating of the analyst that currently disagrees with Constantine
- Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Decreased Target to $5 on, Tuesday, August 23rd, 2022
Contributing Sources